Revance Therapeutics Statistics
Total Valuation
PSTO has a market cap or net worth of 470,116.
| Market Cap | 470,116 |
| Enterprise Value | n/a |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
PSTO has 27.49 million shares outstanding.
| Current Share Class | 27.49M |
| Shares Outstanding | 27.49M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +3.50% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2.37 |
| PB Ratio | -0.63 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.10
| Current Ratio | 0.10 |
| Quick Ratio | 0.09 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.39 |
| Interest Coverage | -136.51 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -3,634.17% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 825.71% |
| Revenue Per Employee | 66,152 |
| Profits Per Employee | -1.91M |
| Employee Count | 3 |
| Asset Turnover | 2.05 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -16.59% in the last 52 weeks. The beta is -1.71, so PSTO's price volatility has been lower than the market average.
| Beta (5Y) | -1.71 |
| 52-Week Price Change | -16.59% |
| 50-Day Moving Average | 0.03 |
| 200-Day Moving Average | 0.18 |
| Relative Strength Index (RSI) | 45.35 |
| Average Volume (20 Days) | 22,067 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 6.83 |
Income Statement
In the last 12 months, PSTO had revenue of 198,455 and -5.72 million in losses. Loss per share was -0.27.
| Revenue | 198,455 |
| Gross Profit | 54,945 |
| Operating Income | -5.63M |
| Pretax Income | -5.72M |
| Net Income | -5.72M |
| EBITDA | -5.58M |
| EBIT | -5.63M |
| Loss Per Share | -0.27 |
Balance Sheet
The company has 1,810 in cash and 156,812 in debt, giving a net cash position of -155,002 or -0.01 per share.
| Cash & Cash Equivalents | 1,810 |
| Total Debt | 156,812 |
| Net Cash | -155,002 |
| Net Cash Per Share | -0.01 |
| Equity (Book Value) | -747,708 |
| Book Value Per Share | -0.03 |
| Working Capital | -761,021 |
Cash Flow
In the last 12 months, operating cash flow was -393,922 and capital expenditures -3,185, giving a free cash flow of -397,107.
| Operating Cash Flow | -393,922 |
| Capital Expenditures | -3,185 |
| Free Cash Flow | -397,107 |
| FCF Per Share | -0.01 |
Margins
| Gross Margin | 27.69% |
| Operating Margin | -2,834.42% |
| Pretax Margin | -2,881.68% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
PSTO does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.67% |
| Shareholder Yield | n/a |
| Earnings Yield | -1,216.47% |
| FCF Yield | -84.47% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
PSTO has an Altman Z-Score of -163.89 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -163.89 |
| Piotroski F-Score | 1 |